Podcasts Science CME Establishing the Role of Immunotherapy in Microsatellite Instability-High (MSI-H) or Mismatch Repair-Deficient (dMMR) Endometrial Cancer

Establishing the Role of Immunotherapy in Microsatellite Instability-High (MSI-H) or Mismatch Repair-Deficient (dMMR) Endometrial Cancer

Published: Nov. 30, 2022, 5 a.m.

Host: Robert L. Coleman, MD, FACOG, FACS
\n\n Guest: Susana Campos, MD, MPH
\n\n Guest: Ana Oaknin, MD, PhD
\n\n\n \n

Are you testing for MSI-H/dMMR in your patients with advanced endometrial cancer? Listen in as Drs. Robert Coleman, Susana Campos, and Ana Oaknin break down the progress being made in biomarker testing and immunotherapy treatment for these patients.